These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 308502)

  • 21. Plasmid-related beta-lactamase production in Bacteroides fragilis strains.
    Nakano V; Padilla G; do Valle Marques M; Avila-Campos MJ
    Res Microbiol; 2004 Dec; 155(10):843-6. PubMed ID: 15567279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical bacteriological studies on the beta-lactamase produced by Bacteroides fragilis (author's transl)].
    Ichikawa M; Miyoshi Y
    Kansenshogaku Zasshi; 1979 May; 53(5):234-42. PubMed ID: 119017
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
    Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
    Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The beta-lactamases of Bacteroides species.
    Timewell R; Taylor E; Phillips I
    J Antimicrob Chemother; 1981 Feb; 7(2):137-46. PubMed ID: 6971286
    [No Abstract]   [Full Text] [Related]  

  • 26. Additional characteristics of Bacteroides fragilis carbapenemases belonging to group 3a.
    Edwards R; Greenwood D
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2591-2. PubMed ID: 9371378
    [No Abstract]   [Full Text] [Related]  

  • 27. Purification, characterization, and kinetic studies of a soluble Bacteroides fragilis metallo-beta-lactamase that provides multiple antibiotic resistance.
    Wang Z; Benkovic SJ
    J Biol Chem; 1998 Aug; 273(35):22402-8. PubMed ID: 9712862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Purification and immunological behavior of beta-lactamase from Bacteroides fragilis].
    Chen J; Liu B; Bao Y
    Wei Sheng Wu Xue Bao; 1991 Feb; 31(1):60-6. PubMed ID: 2035276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The microdilution antibiotic susceptibility test. Bacteroides fragilis.
    Steingrimsson O; Ryan RW; Tilton RC
    Am J Clin Pathol; 1976 Jun; 65(6):1010-5. PubMed ID: 1047602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative stabilities of penicillins and cephalosporins to staphylococcal beta-lactamase and activities against Staphylococcus aureus.
    Selwyn S
    J Antimicrob Chemother; 1980 Nov; 6(6):794-5. PubMed ID: 6969252
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
    Martin MA; Liebana J; Castillo AM; Gutierrez J; Piédrola G
    Microbios; 1991; 67(272-273):195-202. PubMed ID: 1779879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of zinc ions on the activity of metallo-beta-lactamases of Bacteroides fragilis.
    Edwards R; Hashmi PS; Greenwood D
    J Med Microbiol; 1997 Sep; 46(9):807-9. PubMed ID: 9291894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
    Dornbusch K; Nord CE; Olsson-Liljeqvist B
    Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physico-chemical and enzymological properties of beta-lactamase from Bacteroides fragilis].
    Chen J; Liu B; Bao Y
    Wei Sheng Wu Xue Bao; 1990 Dec; 30(6):433-7. PubMed ID: 2270687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Restudies on antibacterial activity of sulbenicillin against anaerobic bacteria (author's transl)].
    Umemura A; Isono M; Yamada N; Kobayashi T; Watanabe K; Ueno K
    Jpn J Antibiot; 1981 Jun; 34(6):976-9. PubMed ID: 7026824
    [No Abstract]   [Full Text] [Related]  

  • 37. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
    Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
    Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interplay of beta-lactamases and intrinsic factors in the resistance of gram-negative bacteria to penicillins and cephalosporins.
    Richmond MH; Curtis NA
    Ann N Y Acad Sci; 1974 May; 235(0):553-68. PubMed ID: 4528040
    [No Abstract]   [Full Text] [Related]  

  • 40. Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria.
    Montgomery K; Raymundo L; Drew WL
    J Clin Microbiol; 1979 Feb; 9(2):205-7. PubMed ID: 34624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.